Md Sohrab Alam | Drug Delivery Systems | Best Researcher Award

Mr. Md Sohrab Alam | Drug Delivery Systems | Best Researcher Award

Lord Buddha Koshi Pharmacy College | India

Mr. Md Sohrab Alam is an accomplished academic and pharmaceutical professional recognized for his expertise in pharmaceutics, quality assurance, research, and teaching excellence. With a strong educational foundation that includes a Bachelor of Pharmacy and Master of Pharmacy in Pharmaceutics from Jamia Hamdard, followed by continued progress in doctoral research at Monad University, he has developed a comprehensive understanding of drug delivery science, formulation technologies, and pharmaceutical regulatory principles. His early engagement in research led to his notable project Nanostructured Lipid Carrier Based Transdermal Drug Delivery System of Pioglitazone, conducted under distinguished supervision at Jamia Hamdard, which strengthened his interests in targeted and advanced drug delivery systems. Professionally, he has gained diverse experience across academia, hospital pharmacy, and industrial quality assurance, beginning with a role as Quality Assurance Officer at Brawn Laboratories Ltd., followed by several fulfilling years as a pharmacist within the Shamsaa Pharmacy Group in Saudi Arabia, where he contributed to patient care, medication safety, and therapeutic guidance. His transition into academics marked a significant phase of his career, serving first as an Assistant Professor at the Nibha Institute of Pharmaceutical Sciences and later advancing to the position of Associate Professor at Lord Buddha Koshi Pharmacy College, where he continues to mentor budding pharmacists and inspire research-driven learning. His research contributions include the publication Nanostructured Lipid Carriers of Pioglitazone for Transdermal Application: From Experimental Design to Bioactivity Detail in the journal Drug Delivery, and the study Effects of Europinidine-O-Methylated Anthocyanidine on Scopolamine-Induced Memory Impairments by Improving Neurological Expression: An Integrated In-Silico and ADMET Computational Analysis, published in Learning and Motivation. He is also the author of the academic book Guide to Pharmaceutics: As per PCI Syllabus, published by Shaswat Publication, and holds a design patent for the Automatic Rotary Monoblock Bottle Filling Machine. His active participation in national and international conferences, presentations on innovative drug delivery approaches, and recognition with honors such as the Young Scientist Award highlight his growing influence in pharmaceutical sciences. With professional interests spanning teaching, quality assurance, and R&D, along with multilingual proficiency in English, Hindi, Arabic, and Urdu, Mr. Md Sohrab Alam continues to advance in his mission to contribute meaningful innovations and knowledge to the world of pharmacy and drug development.

Profile: Orcid

Featured Publications

Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail

Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Dr. Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Universidade de Vigo | Spain

Dr. Lorena García Hevia is a distinguished researcher recognized for her pioneering work at the intersection of nanomedicine, microbiology, and biotechnology. As a member of the Hybrid Nanomaterials Research Group at the Galicia Sur Health Research Institute (IIS Galicia Sur), she has dedicated her career to advancing innovative nanotechnological solutions that address critical biomedical challenges. Her research focuses primarily on the design and application of nanoscale systems to improve therapeutic delivery, particularly within the context of infectious disease management and antimicrobial resistance.Affiliated with the CINBIO (Biomedical Research Center) and the Universidade de Vigo in Spain, Dr. García Hevia brings an interdisciplinary approach that bridges biochemical, genetic, and immunological insights with advanced materials science. Her scientific vision emphasizes the development of intelligent nanocarriers that enhance drug stability, optimize bioavailability, and enable targeted therapy. Through this approach, she contributes to transforming conventional treatments into highly efficient, patient-specific solutions.In her recent publication Nanomedicine for Phage Therapy: Encapsulation Strategies for Enhanced Antimicrobial Efficacy, Dr. García Hevia and her colleagues explore the integration of nanotechnology with bacteriophage therapy to overcome limitations in traditional antimicrobial strategies. Her work demonstrates how encapsulation methods—such as polymeric nanoparticles, liposomes, hydrogels, and nanofibers—can significantly improve the stability, delivery, and therapeutic impact of bacteriophages. These innovative formulations facilitate localized and sustained release, providing powerful alternatives against multidrug-resistant infections.Dr. García Hevia’s research is marked by creativity, precision, and translational relevance. Her investigations into responsive nanocarriers and inorganic nanoparticles have opened new avenues for targeted phage delivery, aligning with global efforts to combat antibiotic resistance through sustainable and effective biotechnological interventions. Beyond her scientific achievements, she is deeply engaged in academic mentorship and collaborative research initiatives that strengthen the connection between laboratory innovation and clinical application.Her contributions continue to shape the evolving field of nanomedicine, positioning her as a leading figure in the development of next-generation antimicrobial therapies. Through her commitment to excellence and scientific innovation, Dr. Lorena García Hevia exemplifies the transformative potential of nanotechnology in redefining the future of infection control and precision therapeutics.

Profile: Google Scholar

Featured Publications

García‐Hevia, L., Bañobre‐López, M., & Gallo, J. (2019). Recent progress on manganese‐based nanostructures as responsive MRI contrast agents. Chemistry–A European Journal, 25(2), 431–441.

García-Hevia, L., Valiente, R., Martín-Rodríguez, R., Renero-Lecuna, C., et al. (2016). Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale, 8(21), 10963–10973.

Rodrigues, R. O., Baldi, G., Doumett, S., García-Hevia, L., Gallo, J., et al. (2018). Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery. Materials Science and Engineering: C, 93, 206–217.

García‐Hevia, L., Villegas, J. C., Fernández, F., Casafont, Í., González, J., et al. (2016). Multiwalled carbon nanotubes inhibit tumor progression in a mouse model. Advanced Healthcare Materials, 5(9), 1080–1087.

García-Hevia, L., Casafont, I., Oliveira, J., Terán, N., Fanarraga, M. L., & Gallo, J. (2022). Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma. Bioactive Materials, 8, 153–164.